Ditchcarbon
  • Contact
  1. Organizations
  2. Shattuck Labs, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 17 days ago

Shattuck Labs, Inc.

Company website

Shattuck Labs, Inc., headquartered in the United States, is a pioneering biotechnology company focused on advancing the field of immunotherapy. Founded in 2016, Shattuck Labs has quickly established itself as a leader in the development of innovative therapies that harness the power of the immune system to combat cancer and other diseases. The company is renowned for its proprietary platforms, including the unique "Dual-Affinity Re-Targeting" (DART) technology, which enables the creation of bispecific therapeutics that can engage multiple targets simultaneously. This innovative approach sets Shattuck Labs apart in the competitive landscape of biopharmaceuticals. With a strong emphasis on research and development, Shattuck Labs has achieved significant milestones, including strategic partnerships and advancing multiple candidates into clinical trials, solidifying its position as a key player in the immuno-oncology sector.

DitchCarbon Score

How does Shattuck Labs, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Shattuck Labs, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

31%

Let us know if this data was useful to you

Shattuck Labs, Inc.'s reported carbon emissions

Shattuck Labs, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. As of now, there are no emissions figures, such as Scope 1, 2, or 3 emissions, to detail. The company has not disclosed any climate commitments or pledges, nor does it appear to inherit emissions data from a parent or related organisation. Without specific data or commitments, it is unclear how Shattuck Labs is addressing climate change or carbon emissions within its operations. In the absence of concrete information, it is essential for Shattuck Labs to establish clear climate goals and transparency in emissions reporting to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shattuck Labs, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Shattuck Labs, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shattuck Labs, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Zai Lab

CN
•
Pharmaceutical Preparation Manufacturing
Updated less than a minute ago

EDITA

FI
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

ALX Oncology Holdings Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 28 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Exelixis, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy